Next Article in Journal
Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease
Next Article in Special Issue
Lead Exposure Causes Spinal Curvature during Embryonic Development in Zebrafish
Previous Article in Journal
Novel Plant Extract Ameliorates Metabolic Disorder through Activation of Brown Adipose Tissue in High-Fat Diet-Induced Obese Mice
 
 
Review
Peer-Review Record

Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19

Int. J. Mol. Sci. 2022, 23(16), 9297; https://doi.org/10.3390/ijms23169297
by Aram Yegiazaryan 1, Arbi Abnousian 1, Logan J. Alexander 1, Ali Badaoui 1, Brandon Flaig 1, Nisar Sheren 1, Armin Aghazarian 1, Dijla Alsaigh 1, Arman Amin 1, Akaash Mundra 1, Anthony Nazaryan 1, Frederick T. Guilford 2,* and Vishwanath Venketaraman 1,*
Reviewer 1:
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2022, 23(16), 9297; https://doi.org/10.3390/ijms23169297
Submission received: 5 August 2022 / Revised: 16 August 2022 / Accepted: 16 August 2022 / Published: 18 August 2022

Round 1

Reviewer 1 Report

Competent, well written review.

Remarks:

The author could consider inserting a table documenting the decrease in GSH content in various viral diseases including the cells/tissues where the GSH level was quantified. It is a suggestion but not a requirement; the review is well balanced in the submitted form.

Fig. 1 Please explain D1, D2

Line 232: “was severely diminished”, wouldn’t “is severely diminished” be better?

Line 240: which isoenzyme of superoxide dismutase?

Lines 276-279: NADPH is required rather for GSH regeneration (from GSSG, by glutathione reductase) than GSH generation

Author Response

Cover letter: Recent Developments in the understanding of immunity, pathogenesis and management of COVID-19.

 

REVIEWER#1

Thank you for reviewing our paper and suggesting the edits stated below, we have looked at all the suggestions and made the necessary revisions as requested by reviewer 1 and 2.

The following comments/remarks:

The author could consider inserting a table documenting the decrease in GSH content in various viral diseases including the cells/tissues where the GSH level was quantified. It is a suggestion but not a requirement; the review is well balanced in the submitted form.

  • Thank you for the suggestion it is a great point but we have decided to not include a table at the time.

Fig. 1 Please explain D1, D2

  • Added parenthesis in the text to explain what they are in the figure.

Line 232: “was severely diminished”, wouldn’t “is severely diminished” be better?

  • Changed “was” to “is”

Line 240: which isoenzyme of superoxide dismutase?

  • Changed to Superoxide dismutase isoform 1 (SOD1) to be more specific

Lines 276-279: NADPH is required rather for GSH regeneration (from GSSG, by glutathione reductase) than GSH generation

  • Changed to “plays a role in the regeneration of GSH”

 

Author Response File: Author Response.docx

Reviewer 2 Report

The authors presented a comprehensive review on the COVID-19. They touch the problem from various sides and consider its different aspects. The only thing I would add to this paper, is some more information about the latest mutations of the omicron variant and also on the changing symptoms/mortality with the subsequent dominating variants of the virus. I would also like to congratulate authors on their great work.

Author Response

Cover letter: Recent Developments in the understanding of immunity, pathogenesis and management of COVID-19.

Thank you for reviewing our paper and suggesting the edits stated below, we have looked at all the suggestions and made the necessary revisions as requested by reviewer 1 and 2.

REVIEWER#2

The authors presented a comprehensive review on the COVID-19. They touch the problem from various sides and consider its different aspects. The only thing I would add to this paper, is some more information about the latest mutations of the omicron variant and also on the changing symptoms/mortality with the subsequent dominating variants of the virus. I would also like to congratulate authors on their great work.

  • Added to the paragraph in section 2.2 with further information on the omicron variant.

Author Response File: Author Response.docx

Back to TopTop